Accelerator’s second NYC biotech startup sets out with $17M and some Gates-backed science

Damian Garde

Accelerator, among the financiers looking to kick-start a fledgling hub in New York City, launched its local project in the form of Lodo Therapeutics, a company working to turn natural products into novel therapies.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS